Somatic mutations of the CREBBP and EP300 genes affect response to histone deacetylase inhibition in malignant DLBCL clones

Leukemia Research Reports

Volumn 2, Issue 1, 2013, Pages 1-3

  Andersen, Christen Lykkegaard ^a,b   Asmar, Fazila ^b   Klausen, Tobias ^c   Hasselbalch, Hans ^a   Grønbæk, Kirsten ^b  

^a ROSKILDE HOSPITAL   (Denmark)

^b Mental Health Services CPH   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Diffuse large B cell lymphoma; Histone acetyl transferase; Histone deacetylase inhibition; Somatic mutation; Vorinostat

Indexed keywords

HISTONE DEACETYLASE INHIBITOR; VORINOSTAT;

APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREBBP GENE; DRUG RESPONSE; EP300 GENE; LARGE CELL LYMPHOMA; LYMPHOMA CELL LINE; PRIORITY JOURNAL; SOMATIC MUTATION; WILD TYPE;

EID: 84878362044     PISSN: 22130489     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lrr.2012.10.002     Document Type: Article

References (9)

1. Brooks C.L., Gu W. The impact of acetylation and deacetylation on the p53 pathway. Protein & Cell 2011, 2:456-462.
2. Mullighan C.G., Zhang J., Kasper L.H., Lerach S., Payne-Turner D., Phillips L.A., et al. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 2011, 471:235-239.
3. Pasqualucci L., Dominguez-Sola D., Chiarenza A., Fabbri G., Grunn A., Trifonov V., et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 2011, 471:189-195.
4. Schiltz R.L., Mizzen C.A., Vassilev A., Cook R.G., Allis C.D., Nakatani Y. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. Journal of Biological Chemistry 1999, 274:1189-1192.
5. Wang H., Walsh S.T., Parthun M.R. Expanded binding specificity of the human histone chaperone NASP. Nucleic Acids Research 2008, 36:5763-5772.
6. Bereshchenko O.R., Gu W., Dalla-Favera R. Acetylation inactivates the transcriptional repressor BCL6. Nature Genetics 2002, 32:606-613.
7. Phan R.T., Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 2004, 432:635-639.
8. Cohen I., Poreba E., Kamieniarz K., Schneider R. Histone modifiers in cancer: friends or foes?. Genes & Cancer 2011, 2:631-647.
9. Andersen C.L., Hasselbalch H., Grønbæk K. Lack of somatic mutations in the catalytic domains of CREBBP and EP300 genes implies a role for histone deacetylase inhibition in myeloproliferative neoplasms. Leukemia Research 2012, 36:485-487.